Serveur d'exploration sur l'Indium - Analysis (France)

Index « Auteurs » - entrée « Eric Mirallié »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Eric Levoirier < Eric Mirallié < Eric Nguyen-Khac  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 4.
Ident.Authors (with country if any)Title
000022 (2012) Pretargeted radioimmunotherapy (pRAIT) in medullary thyroid cancer (MTC).
000023 (2012) Phase II trial of anticarcinoembryonic antigen pretargeted radioimmunotherapy in progressive metastatic medullary thyroid carcinoma: biomarker response and survival improvement.
000116 (2005) Improved pretargeted delivery of radiolabelled hapten to human tumour xenograft in mice by avidin chase of circulating bispecific antibody.
000139 (2002) Enhanced antitumor activity of combined pretargeted radioimmunotherapy and paclitaxel in medullary thyroid cancer xenograft.

List of associated KwdEn.i

Nombre de
documents
Descripteur
4Animals
4Humans
3Mice
2Carcinoembryonic Antigen (immunology)
2Combined Modality Therapy
2Iodine Radioisotopes (therapeutic use)
2Mice, Nude
2Neoplasm Metastasis
2Radioimmunotherapy
2Radioimmunotherapy (methods)
2Thyroid Neoplasms (pathology)
2Thyroid Neoplasms (radiotherapy)
1Adult
1Aged
1Aged, 80 and over
1Antibodies (blood)
1Antibodies (immunology)
1Antibodies (therapeutic use)
1Antibodies, Bispecific
1Antibodies, Bispecific (adverse effects)
1Antibodies, Bispecific (therapeutic use)
1Antibodies, Monoclonal, Humanized (adverse effects)
1Antibodies, Monoclonal, Humanized (therapeutic use)
1Avidin (administration & dosage)
1Carcinoembryonic Antigen (blood)
1Carcinoembryonic Antigen (therapeutic use)
1Carcinoma (metabolism)
1Carcinoma (radiotherapy)
1Carcinoma, Medullary (pathology)
1Carcinoma, Medullary (therapy)
1Cell Line, Tumor
1Colonic Neoplasms (metabolism)
1Colonic Neoplasms (radiotherapy)
1Disease Progression
1Doxorubicin (therapeutic use)
1Drug Combinations
1Drug Delivery Systems (methods)
1Female
1Immunoglobulin G (therapeutic use)
1Iodine Radioisotopes (pharmacokinetics)
1Male
1Metabolic Clearance Rate (drug effects)
1Middle Aged
1Neoplasm Transplantation
1Neoplasms, Experimental
1Organ Specificity (drug effects)
1Paclitaxel (therapeutic use)
1Pentetic Acid (analogs & derivatives)
1Pentetic Acid (immunology)
1Pentetic Acid (therapeutic use)
1Prognosis
1Protein Kinase Inhibitors (therapeutic use)
1Radiation-Sensitizing Agents (therapeutic use)
1Radioimmunotherapy (adverse effects)
1Survival Analysis
1Thyroid Neoplasms (diagnosis)
1Thyroid Neoplasms (drug therapy)
1Thyroid Neoplasms (metabolism)
1Thyroid Neoplasms (therapy)
1Tissue Distribution (drug effects)
1Transplantation, Heterologous
1Treatment Outcome
1Tumor Cells, Cultured
1Tumor Markers, Biological (metabolism)
1Young Adult

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=IndiumV2/Data/France/Analysis
HfdIndexSelect -h $EXPLOR_AREA/Data/France/Analysis/Author.i -k "Eric Mirallié" 
HfdIndexSelect -h $EXPLOR_AREA/Data/France/Analysis/Author.i  \
                -Sk "Eric Mirallié" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/France/Analysis/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=   *** parameter Area/wikiCode missing *** 
   |area=    IndiumV2
   |flux=    France
   |étape=   Analysis
   |type=    indexItem
   |index=    Author.i
   |clé=    Eric Mirallié
}}

Wicri

This area was generated with Dilib version V0.5.76.
Data generation: Tue May 20 07:24:43 2014. Site generation: Thu Mar 7 11:12:53 2024